An interventional study of cognitive Therapy by artificial intillegence and designed physical-therapy program in Multiple Sclerosis, sponsored by Cairo University. Not yet recruiting. Open to participants aged 25 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-08-13.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
this study will be conducted to investigate the effect of artificial intelligence (AI) based cognitive training on sleep disorders and quality of life in patients with multiple sclerosis.
Multiple sclerosis (MS) is a chronic progressive inflammatory autoimmune neurodegenerative disease of central nervous system (CNS) and it is considered to be the most prevalent neurological disability of young adults, often leads to severe physical or cognitive incapacitation. The severity of disability in MS patients is increased not only by motor disorders and other neurological deficit, but by the presence of cognitive impairment (CI), psycho-emotional disorders, like anxiety and/or depression, and sleep disorders (SD). Cognitive dysfunction is one of the most common and consequential symptoms of MS. Impairments in processing speed, working memory, learning, executive function, visuospatial processing, and language function affect an estimated 42% to70% of individuals with MS, and constitute a major cause of loss of employment and reduced quality of life. Despite its high prevalence and effect, there are no definitive treatments for cognitive dysfunction in MS, and the identification of appropriate strategies to improve cognition in MS is hindered by a poor understanding of modifiable factors that may influence its severity. AI is playing a significant role in harnessing neuroplasticity for cognitive enhancement through innovative applications such as cognitive training programs.These programs, driven by machine learning algorithms, can adapt to individual user performance, providing personalized training that optimizes cognitive functions such as memory, attention, and problem-solving .
3,264 studies on the registry are indexed under Multiple Sclerosis; 659 are open to participants now.
This study's planned enrollment of 40 is below the median of 50 across 2,201 interventional studies indexed under Multiple Sclerosis.
Browse Multiple Sclerosis studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Twenty patients with multiple sclerosis will receive a cognitive therapy by Lumosity application in addition to a designed physical-therapy program 3 times per week for 8 weeks
Other: cognitive Therapy by artificial intillegence · Other: designed physical-therapy program
Twenty patients with multiple sclerosis will receive a designed physical-therapy program 3 times per week for 8 weeks)
Other: designed physical-therapy program
The patients will receive cognitive therapy by an artificial intelligence application called Lumosity. Lumosity is an online cognitive training that can incredibly engage the individual's innate neuroplasticity, making the person smarter. Perhaps Lumosity training actually increases the release of dopamine, the neurochemical that is very crucial for many brain functions, and the puls-designed physical therapy program
Patients will receive designed physical-therapy program in the form of sleep and bedtime restrictions, stimulus control instructions, education for sleep and promoting good sleep habits (or sleep hygiene), teaching relaxation skills
sleep disability
Pittsburgh Sleep Quality Index will be used to assess sleep disability. it gives impression on sleep quality, sleep latency, sleep duration, usual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction over one month, The sum of scores for these seven components yields one global score. Scoring of the answers is based on a 0 to 3 scale and a global sum equal or larger than 5 indicates a "poor" sleeper
Time frame: up to eight weeks
daytime sleepiness
Epworth Sleepiness Scale will be used to assess daytime sleepiness. It measures the general level of daytime sleepiness it is composed of 8 items to rate on a 4 -point scale (0-3). A higher score indicates higher level of daytime sleepiness. Using a cut-off score \> 10, it is possible to identify individuals with excessive daytime sleepiness. Scores \>16 indicates ever sleepiness
Time frame: up to eight weeks
cognitive disability
CogniFit will be used to assess cognitive function. it is a digital health platform offering computerized cognitive assessments and interventions for users, researchers, and practitioners. The CogniFit cognitive score is an aggregate measure of your brain's performance across 20 more different cognitive skills. The scale ranges from a minimum of 0 to a maximum of 800, evaluated against normalized data matched to your specific age and gender. 0 - 200 (Red): Below average for your age and sex; highlights a cognitive weakness. 200 - 400 (Yellow): Low range, but still within the normal average and open to improvement. 400-600 (Green): High score within the average; indicates good condition relative to peers.600-800 (Green): Above average; signals a distinct cognitive strength or skil.
Time frame: up to eight weeks
oxygen saturation
A smartwatch will be used to assess oxygen saturation.
Time frame: up to eight weeks
heart rate
A smartwatch will be used to assess heart rate
Time frame: up to eight weeks
life disability
World Health Organization Quality of Life Assessment Brief will be used to assess life disability. it has a four-domain structure which are physical health, psychological domain, social domain and environmental domain to provide a short-form quality of life assessment. Subjects rated all items on a 5-point Likert-type scale. Raw scores for the domains of WHOQOL-BREF were calculated by adding values of single items and were transformed on the scale ranging from 0 to 100 where 100 is the highest and 0 the lowest.
Time frame: up to eight weeks
fatigue severity
The fatigue severity scale FSS will be used to assess fatigue severity. it is a self-report scale with nine items that assess the degree of physical fatigue over the previous week. The Fatigue Severity Scale (FSS) is scored by adding the answers to 9 questions and finding the total sum or the average mean. Each question uses a 7-point scale from 1 (strongly disagree) to 7 (strongly agree) based on the past week. Add all 9 numbers together. The total score ranges from 9 to 63.Divide the total sum by 9. The average score ranges from 1.0 to 7.0.a higher score indicates more severity
Time frame: up to eight weeks
No study locations are listed for this record.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.